CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Planned sale Chief Discovery/Trans Medicine sold 7,940 shares at an average $36.89 ($292,904)
- 144/A Insider Sale of Securities
- 4 Planned sale Director sold 2,911 shares at an average $38.06 ($110,788)
- 4 Planned sale Director sold 3,934 shares at an average $38.07 ($149,759)
- 4 Planned sale Director sold 3,147 shares at an average $38.06 ($119,787)
- 4 Planned sale Director sold 4,720 shares at an average $38.10 ($179,813)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 74 shares at $33.89 ($2,508)
- 4 Planned sale Chief Financial Officer sold 16,104 shares at an average $35.27 ($567,910)
- 4 Planned sale Chief Medical Officer sold 8,303 shares at an average $35.26 ($292,804)
- 4 Planned sale Chief Discovery/Trans Medicine sold 38,443 shares at an average $34.69 ($1,333,529)
- 4 Planned sale COO and General Counsel sold 33,190 shares at an average $34.36 ($1,140,362)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 12 of 69 · 1,363 filings